Affiliation:
1. Department of Biochemistry and Molecular Genetics, College of Medicine, University of Illinois at Chicago , MBRB2074, MC669, 900 S. Ashland Ave, Chicago, IL 60607 , United States
2. Department of Large Animal Clinical Sciences, College of Veterinary Medicine, University of Florida , 2015 SW 16th Ave, Gainesville, FL 32610 , United States
Abstract
Abstract
The origins and evolution of the eosinophilic leukocyte have received only scattered attention since Paul Ehrlich first named this granulocyte. Studies suggest that myeloperoxidase, expressed by granulocytes, and eosinophil peroxidase diverged some 60 to 70 million years ago, but invertebrate to vertebrate evolution of the eosinophil lineage is unknown. Vertebrate eosinophils have been characterized extensively in representative species at light microscopic, ultrastructural, genetic, and biochemical levels. Understanding of eosinophil function continues to expand and includes to date regulation of “Local Immunity And/Or Remodeling/Repair” (the so-called LIAR hypothesis), modulation of innate and adaptive immune responses, maintenance of tissue and metabolic homeostasis, and, under pathologic conditions, inducers of tissue damage, repair, remodeling, and fibrosis. This contrasts with their classically considered primary roles in host defense against parasites and other pathogens, as well as involvement in T-helper 2 inflammatory and immune responses. The eosinophils’ early appearance during evolution and continued retention within the innate immune system across taxa illustrate their importance during evolutionary biology. However, successful pregnancies in eosinophil-depleted humans/primates treated with biologics, host immune responses to parasites in eosinophil-deficient mice, and the absence of significant developmental or functional abnormalities in eosinophil-deficient mouse strains under laboratory conditions raise questions of the continuing selective advantages of the eosinophil lineage in mammals and humans. The objectives of this review are to provide an overview on evolutionary origins of eosinophils across the animal kingdom, discuss some of their main functions in the context of potential evolutionary relevance, and highlight the need for further research on eosinophil functions and functional evolution.
Funder
Food
and Drug Administration
National
Institutes of Health
National Heart, Lung, and Blood Institute
American Partnership for Eosinophilic Disorders
UIC Chancellors Innovation Fund
End Allergies Together (EAT) Foundation
Chicago Biomedical Consortium
Accelerator Network
CBC Director's Fund
Publisher
Oxford University Press (OUP)